人才培养模式

我国过敏反应专科医师培养方案探析

  • 张书辰 ,
  • 易玲玲 ,
  • 刘光辉 ,
  • 邵莉
展开
  • 1华中科技大学同济医学院附属同济医院过敏反应科,武汉 430030;
    2华中科技大学同济医学院附属同济医院呼吸与危重病学科,武汉 430030;
    3武汉大学中南医院过敏反应科 430071;
    4上海交通大学医学院附属仁济医院过敏科 200127

网络出版日期: 2021-10-29

基金资助

国家自然科学基金(81800026)

The analysis of training for allergists in China

  • Zhang Shuchen ,
  • Yi Lingling ,
  • Liu Guanghui ,
  • Shao Li
Expand
  • 1Department of Allergy, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China;
    2Department of Respiratory and Critical Care Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China;
    3Department of Allergy, Zhongnan Hospital, Wuhan University, Wuhan 430071, China;
    4Department of Allergy, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China

Online published: 2021-10-29

Supported by

National Natural Science Founding of China (81800026)

摘要

过敏性疾病是全球常见的疾病之一,过敏反应学科人才培养将在临床医学中越来越受到重视。目前,全球过敏反应专科教育体制尚未完备,大多数的基础临床教育并没有涵盖过敏性疾病等免疫系统相关疾病的教育,这阻碍了过敏反应专科的发展。本文分析过敏反应专科概况,提出过敏反应专科建设的必要性与培养方案,为发展中国过敏反应专科和人员培训提供参考。

本文引用格式

张书辰 , 易玲玲 , 刘光辉 , 邵莉 . 我国过敏反应专科医师培养方案探析[J]. 中华医学教育杂志, 2021 , 41(11) : 966 -969 . DOI: 10.3760/cma.j.cn115259-20210421-00528

Abstract

Allergic disease is one of the most common diseases in the world, and so the training of healthcare providers in this field is quite important. At the present, the education system of allergology over the world is not well functioning. Most clinical education does not cover the independent training on allergic diseases and other immune diseases, which impedes the development of education and training on allergic diseases. Based on the analysis of the current status of global profile of allergist training, and the profile of department of allergy, this article provides potential countermeasure of development of allergist education and training to tackle to the challenge.

参考文献

[1] Asher I, Baena-Cagnani C, Boner A, et al. World Allergy Organization guidelines for prevention of allergy and allergic asthma[J]. Int Arch Allergy Immunol, 2004,135(1):83-92. DOI: 10.1159/000080524.
[2]Pawankar R, Caonica GW, Holgate ST, et al. World Allergy Organization (WAO) white book on allergy 2011-2012: executive summary[J]. Japanese Journal of Allergology, 2011, 60:9-17.
[3]Weinberg EG. The WAO white book on allergy 2011-2012: review article[J]. Current Allergy & Clinical Immunology, 2011, 24(3):156-157.
[4]Warner JO, Kaliner MA, Crisci CD, et al. Allergy practice worldwide: a report by the World Allergy Organization Specialty and Training Council[J]. Int Arch Allergy Immunol, 2006,139(2):166-174. DOI: 10.1159/000090502.
[5]Gerth van Wijk R, Eguiluz-Gracia I, Gayraud J, et al. The roadmap for allergology in Europe: the subspecialty of allergology as “stop-over” on the way to a full specialty. An EAACI position statement[J]. Allergy, 2018,73(3):540-548. DOI: 10.1111/all.13321.
[6]de Monchy JG, Demoly P, Akdis CA, et al. Allergology in Europe, the blueprint[J]. Allergy, 2013,68(10):1211-1218. DOI: 10.1111/all.12225.
[7]Kaliner MA, Del Giacco S, Crisci CD, et al. Requirements for physician competencies in allergy: key clinical competencies appropriate for the care of patients with allergic or immunologic diseases: a position statement of the world allergy organization[J]. World Allergy Organ J, 2008,1(2):42-46. DOI: 10.1097/WOX.0b013e3181651689.
[8]Mothes-Luksch N, Jordakieva G, Hinterhlzl L, et al. Allergy diagnosis from symptoms to molecules, or from molecules to symptoms: a comparative clinical study[J]. World Allergy Organ J, 2018,11(1):22. DOI: 10.1186/s40413-018-0199-y.
[9] Aberer BVW. Risks and safety requirements for diagnostic and therapeutic measures in allergology: a statement of the World Allergy Organization (WAO)[J]. Allergologie, 2017, 40(2):86-87.
[10]Kowalski ML, Ansotegui I, Aberer W, et al. Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement[J]. World Allergy Organ J, 2016,9(1):33. DOI: 10.1186/s40413-016-0122-3.
[11]中华预防医学会过敏病预防与控制专业委员会预防食物药物过敏学组. 药物激发试验专家共识[J].中华预防医学杂志,2020,54(10):1060-1068. DOI: 10.3760/cma.j.cn112150-20200711-00997.
文章导航

/